top of page

At the Heart of it all

Authors:

Dr. Bryant Wyatt Ph.D
Department of Mathematics
Tarleton State University
Stephenville, Texas wyatt@tarleton.edu

Brandon Wyatt
Clinical Specialist Electrophysiology
Fort Worth, Texas
BWyatt5@its.JNJ.com

Avery Campbell
Department of Computer Science and Electrical Engineering
Tarleton State University
Stephenville, Texas
avery.campbell@go.tarleton.edu

Gavin McIntosh
Department of Mathematics
Tarleton State University
Stephenville, Texas
gavin.mcintosh@go.tarleton.edu

Modeling Supraventricular Tachycardia Using Dynamic Computer-Generated Left Atrium

Abstract

Supraventricular Tachycardia (SVT) is when the heart’s upper chambers, the atria, beat either too quickly or out of rhythm with the heart’s lower chambers, the ventricles. This out-of-step beating of the heart is not, in itself, deadly but is indirectly the leading cause of strokes, heart attacks, and heart failure. The most successful treatment for most forms of SVT is catheter ablation. In this process, an electrophysiologist (EP) makes a three-dimensional mapping of the heart to find areas with abnormal electrical activity. The EP then runs a catheter up the femoral vein near the groin up to the heart and uses RF energy to burn the abnormal area in the heart to produce scar tissue that blocks the electrical signals. Though ablation and three-dimensional imaging technology have made considerable advancements over the last ten years, a great deal is still not known about what triggers SVT and where to create scar tissue for optimal tachycardia elimination. We have produced a discrete model of the left atrium that is adjustable down to the individual muscle level. The model beats in real-time and allows the users to dynamically interact with a running simulation. The user can change muscle attributes, insert ectopic signals, and ablate sections of the heart. This work will allow doctors and researchers to rapidly gain insight into what causes SVTs and how to terminate them without the risks and time constraints of experimenting on living hearts. This project has the potential to save millions of lives. 

CSS CONCEPTS

• Applied Computing → Life and medical sciences → Health care information systems; Systems biology;

KEYWORDS

health informatics; dynamic; electrophysiology; modeling, tachycardia; heart disease

ACM Reference format:

Bryant Wyatt, Avery Campbell, Melanie Little, Brandon Wyatt, and Gavin McIntosh. 2021. Modeling Supraventricular Tachycardia Using a Dynamic Computer-Generated Left Atrium. In Proceedings of SC Supercomputing Conference (SC’22). SC22, Dallas, TX, USA, 2 pages.

Introduction

The leading cause of death globally is heart disease followed by strokes. Supraventricular Tachycardia (SVT), though not in itself deadly, is a leading cause of strokes, heart attacks, and heart failure. Therefore, one could argue that SVT is indirectly a leading global killer [1-7]. SVT is a term that encompasses all events where the atria beat too rapidly or are out of sync with the ventricles, this includes atrial fibrillation (AF), atrial flutter, and a multitude of other atrial tachycardias [3, 4, 8-14]. This out-of-sync beating between the atria and the ventricles can cause blood to pool in the atria creating clots that can then travel to the brain or coronary arteries resulting in stroke or heart attack [3, 4, 8]. SVT events also greatly reduce the stroke volume of the heart and if they persist for extended periods of time they can cause a permanent reduction in ejection fraction, possibly resulting in congestive heart failure [15]. 

SVT events occur when rogue electrical impulses interfere with the normal sinus rhythm of the heart. In a normally functioning heart, the sinus node acts as an orchestra conductor and methodically sends out a periodic electrical impulse. This electrical pulse starts a chain reaction throughout the heart causing the muscles of the heart (myocardium) to rhythmically contract to produce an orchestrated beat. Rogue electrical impulses can cause chain reactions to occur at the wrong place and at the wrong time, disrupting the sinus rhythm [2]. This can cause the atria to flutter, beat out of step with the ventricles, or have a myriad of other undesirable outcomes. The beating heart is a three-dimensional nonlinear dynamical system that is sensitive to initial conditions. Hence, SVT events can produce chaotic outcomes that are impossible to predict analytically and must be simulated numerically on high-performance computers.

Traditional Procedures 

SVT events can sometimes be successfully controlled with drugs, but the patient can build up a tolerance and doses must be increased over time. The downside to drug treatment for stopping SVT is that these drugs can be extremely hard on the liver and can lead to liver failure. Hence, although much more invasive, catheter ablation has proven to be the method of choice when treating SVTs [6, 16, 17-19]. 

Problem Statement 

Radiofrequency catheter ablation and three-dimensional mapping techniques have greatly improved over the last ten years, allowing doctors to perform procedures on beating hearts. But the beating heart can be a chaotic system, making it extremely difficult to predict precisely what outcome will result from changes to the system such as those introduced by ablation lesions [3, 4]. Hence, most ablations are limited to educated guesses that doctors hope will result in positive outcomes. Educated guesses are refined and improved through trial and error [6, 20-22]. Trial and error on living patients have obvious downsides and limitations. What is needed is a way to test out ideas that are not so deadly, costly, and time-consuming. Doctors and researchers need a computer-generated dynamical model of the heart that they can perform experiments on. We have created such a model that will beat in real-time so doctors and researchers can study SVT events and how to remove them to return the heart to sinus rhythm.

MODELING

 

Proof of Concept

First, a one-dimensional model allowed visualization of the flow of action potential through a single accurately scaled bundle of cardiac muscles [10-12].

 

 

 

 

 

 

 

 

 

 

Moving up in dimension, a two-dimensional model was created to reproduce various known tachycardia types that occur throughout the heart and pulmonary veins [6, 16, 18, 19, 23].

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

In a two-dimensional loop, we were able to demonstrate the active effects of ablation. Using this, atrioventricular nodal reentry tachycardia (AVNRT) evolves naturally, which we then could eliminate through ablation. Having shown this, we advanced to a three-dimensional model.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

In this dimension, we were able to create branching structures to accurately simulate cardiac muscle tissue. With the right initial conditions, we invoked the evolution of several atrial tachycardias. At this point, the nodal count significantly increased, and we transitioned to parallel processing.

Model Verification 

Patients with AF have the majority of malfunctions in the left atrium, hence this is the area our work focuses on [6, 8, 15, 18, 19, 24-26].

 

 

 

 

 

 

 

 

To substantiate the model, common symptoms that are known to cause atrial flutter were introduced. We managed to produce roof-dependent atrial flutter and mitral flutter accurately. These induced arrhythmias were eliminated with simulated ablations. Next, we moved on to AF. AF is the most prevalent cardiac arrhythmia and the least understood. It is characterized by chaotic electrical signals that cause an erratic beat in the atria [3, 4, 8-14, 24].

 

 

 

 

 

 

 

 

 

We introduced conditions in the model that would bring about AF which closely matched what is seen in clinical cases [2-4, 6, 8, 24, 27].

Patient-Specific

The ultimate goal of this project is to produce patient-specific models that EPs can use to assess procedures before going into surgery. We have been able to produce models given sets of assets and muscle attributes [28].

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

We are currently working to get clinical data to refine our model. We hope that this will enable us to come up with new techniques to benefit patients with extreme cases.

METHODS

The code was written in C/C++ and CUDA. The simulations were accelerated on CUDA-enabled NVIDIA GPUs. OpenGL was used to visualize the simulations. The model assets were generated with Blender using Blender’s python package BPY. Nsight Systems were used to help extend CUDA acceleration techniques.

Melanie Little
Department of Mathematics
Tarleton State University
Stephenville, Texas
melanie.little@go.tarleton.edu

References

[1] Wynsberghe DV, Carola R, Noback CR. 1995. Human Anatomy and Physiology (3rd ed.). McGraw-Hill, London. 

[2] Dubin D. 2007. Rapid Interpretation of EKG's: ... an Interactive Course (6th ed.). Cover Publishing Company, Fort Myers, FL. 

[3] Fogoros RN.  2012. Electrophysiologic Testing (5th ed.). John Wiley & Sons, Incorporated, Hoboken, NJ.  

[4] Klabunde RE. 2021. Cardiovascular Physiology Concepts. Wolters Kluwer, Philadelphia, PA. 

[5] Shen MJ, Zipes DP. 2014. Role of the autonomic nervous system in modulating cardiac arrhythmias. Circulation research,  114, 6 (May 2014), 1004–1021. https://doi.org/10.1161/CIRCRESAHA.113.302549. 

[6] Staerk L, Sherer JA, Ko D, Benjamin EJ, Helm RH. 2017. Atrial Fibrillation: Epidemiology, Pathophysiology, and Clinical Outcomes. Circulation research, 120, 9 (April 2017), 1501–1517. https://doi.org/10.1161/CIRCRESAHA.117.309732. 

[7] Dominic P, Ahmad J, Awwab H, et al. 2021. Stimulant Drugs of Abuse and Cardiac Arrhythmias. Circulation: Arrhythmia and electrophysiology, 15, 1 (December 2021), e010273. https://doi.org/10.1161/CIRCEP.121.010273. 

[8] Pellman J, Sheikh F. 2015. Atrial fibrillation: mechanisms, therapeutics, and future directions. Compr Physiol, 5, 2 (April 2015), 649-665.  doi:10.1002/cphy.c140047. 

[9] Bozkurt S. 2019. Mathematical modeling of cardiac function to evaluate clinical cases in adults and children. PLOS ONE, 14, 10 (October 2019), e0224663. https://doi.org/10.1371/journal.pone.0224663. 

[10] Irie T, Kaneko Y, Nakajima T, et al. 2014. Electroanatomically estimated length of slow pathway in atrioventricular nodal reentrant tachycardia. Heart Vessels, 29, 6 (November 2014), 817-824. doi:10.1007/s00380-013-0424-0. 

[11] Emig R, Zgierski-Johnston CM, Timmermann V, et al.  2021. Passive myocardial mechanical properties: meaning, measurement, models. Biophysical Review, 13, 5 (October 2021), 587-610. doi: 10.1007/s12551-021-00838-1. 

[12] Zoni-Berisso M, Lercari F, Carazza T, Domenicucci S. 2014. Epidemiology of atrial fibrillation: European perspective. Clinical epidemiology, 6, (June 2014), 213–220. https://doi.org/10.2147/CLEP.S47385. 

[13] Carpenter A, Frontera A, Bond R, Duncan E, Thomas G. 2015. Vagal atrial fibrillation: What is it and should we treat it?. International journal of cardiology, 201, (December 2015), 415–421. https://doi.org/10.1016/j.ijcard.2015.08.108. 

[14] Grant A. O. 2009. Cardiac ion channels. Circulation: Arrhythmia and electrophysiology, 2, 2 (April 2009), 185–194. https://doi.org/10.1161/CIRCEP.108.789081. 

[15] Gomez-Outes A, Suarez-Gea ML, Garcia-Pinilla JM. 2017. Causes of death in atrial fibrillation: Challenges and opportunities. Trends in Cardiovascular Medicine, 27, 7 (October

[16] Kneller J, Zou R, Vigmond EJ, Wang Z, Leon LJ, Nattel, S. 2002. Cholinergic atrial fibrillation in a computer model of a two-dimensional sheet of canine atrial cells with realistic ionic

[17] Karki DB, Pant S, Yadava SK, Vaidya A, Neupane DK, Joshi S. 2014. Measurement of right atrial volume and diameters in healthy Nepalese with normal echocardiogram. Kathmandu Univ Med J (KUMJ), 12, 46 (June 2014), 110-112. doi:10.3126/kumj.v12i2.13655. 

[18] Lodish H, Berk A, Zipursky SL, et al. 2000. Molecular Cell Biology (4th ed.). W. H. Freeman, New York, NY. 

[19] Yin S, Zhang X, Zhan C, Wu J, Xu J, Cheung J. 2005. Measuring single cardiac myocyte contractile force via moving a magnetic bead. Biophys J, 88, 2 (February 2005), 1489-1495. doi:10.1529/biophysj.104.048157. 

2017), 494-503. https://doi.org/10.1016/j.tcm.2017.05.002. 

[20] Loring Z, Holmes DN, Matsouaka RA, et al. 2020. Procedural Patterns and Safety of Atrial Fibrillation Ablation: Findings From Get With The Guidelines-Atrial Fibrillation. Circulation: Arrhythmia and electrophysiology, 13, 9 (July 2020), e007944. https://doi.org/10.1161/CIRCEP.119.007944. 

[21] Schauerte P, Scherlag BJ, Pitha J, et al. 2000. Catheter ablation of cardiac autonomic nerves for prevention of vagal atrial fibrillation. Circulation, 102, 22 (November 2000), 2774–2780. https://doi.org/10.1161/01.cir.102.22.2774. 

[22] Verma A, Boersma L, Haines DE, et al. 2021. First-in-Human Experience and Acute Procedural Outcomes Using a Novel Pulsed Field Ablation System: The PULSED AF Pilot Trial. Circulation: Arrhythmia and electrophysiology, 15, 1 (December 2021), e010168. https://doi.org/10.1161/CIRCEP.121.010168. 

properties. Circulation research, 90, 9 (May 2002), E73–E87. https://doi.org/10.1161/01.res.0000019783.88094.ba. 

[23] Attia ZI, Friedman PA, Noseworthy PA, et al. 2019. Age and Sex Estimation Using Artificial Intelligence From Standard 12-Lead ECGs. Circulation: Arrhythmia and electrophysiology, 12, 9 (August 2019), e007284. https://doi.org/10.1161/CIRCEP.119.007284. 

[24] Heijman J, Erfanian Abdoust P, Voigt N, Nattel S, Dobrev D. 2015. Computational models of atrial cellular electrophysiology and calcium handling, and their role in atrial fibrillation. The Journal of physiology, 594, 3 (November 2015), 537–553. https://doi.org/10.1113/JP271404. 

[25] Xu J, Gao Y, Liu C, Wang Y. 2022. Radiofrequency ablation for treatment of atrial fibrillation with the use of intracardiac echocardiography versus without intracardiac echocardiography: A meta-analysis of observational and randomized studies. J Cardiovasc Electrophysiol, 33, 5 (May 2022), 897-907. doi: 10.1111/jce.15423. 

[26] Charitakis E, Metelli S, Karlsson LO. et al. 2022. Comparing efficacy and safety in catheter ablation strategies for atrial fibrillation: A network meta-analysis. BMC Medicine.  20, (May 2022), Article 193. https://doi.org/10.1186/s12916-022-02385-2. 

[27] Niederer SA, Lumens J, Trayanova NA. 2018. Computational models in cardiology. Nature reviews cardiology, 16, 2 (October 2018), 100–111. https://doi.org/10.1038/s41569-018-0104-y. 

[28] Lombardo DM, Fenton FH, Narayan SM, Rappel WJ. 2016. Comparison of Detailed and Simplified Models of Human Atrial Myocytes to Recapitulate Patient Specific Properties. PLoS computational biology, 12, 8 (August 2016), e1005060. https://doi.org/10.1371/journal.pcbi.1005060. 

bottom of page